Stephanie Mompoint is a research APRN at the University of Miami.
Education Reassures Patients With MM Receiving Subcutaneous Daratumumab
Education before subcutaneous daratumumab administration can both reassure patients and reduce the occurrence of adverse events, according to Stephanie Mompoint, APRN.
Sonrotoclax/Zanubrutinib Generates Durable Response in R/R MCL
Q&A: Nursing Considerations From Immune Cell Effector Therapy Experts
Proactive Rash Management Vital for PI3K, AKT Inhibition in Breast Cancer
Understanding How On-Target and Off-Target ADC Toxicities Work